Latest Conference Articles

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss challenges pharmacists may face while expanding into the health and wellness space.

Guillermo Rodriguez Navarrete, the founder and CEO of Nutrillermo, and Elaine Ladd, the chief pharmacy officer of Pharmacy Development Services (PDS), discuss the 2021 Virtual PDS Conference session on growth opportunities in the health and wellness space for pharmacy.

Simko discussed how to retain new patients to continue to bring in new opportunities and better results for pharmacies everywhere.

Pharmacy Times spoke with Lauren Simko, managing performance specialist at Pharmacy Development Services, about her presentation "Elevated Patients Experiences: Lengthen the Patient Lifecycle to Increase Revenue."

In addition to improving health care access for patients, point-of-care testing in pharmacies can drive customer demand and satisfaction.

Heart failure can involve multiple factors, but heart muscle scarring is thought to be an important contributing factor in up to two-thirds of patients with HFpEF.

Patient engagement programs should continually evolve in order to meet patient needs and behaviors.

With the creation of a diabetes prevention program, participants are able to make lasting behavioral changes, such as eating healthier, increasing physical activity, and improving problem-solving skills.

High engagement and collaboration between health systems and health plans is essential to implementing value-based models, according to a session at the Pharmacy Quality Alliance 2021 Annual Conference.

Policy changes impacting the star ratings for 2022 include additional flexibility provided during the COVID-19 pandemic and a revised Extreme and Uncontrollable Circumstances policy.

Awards honor an individual and community pharmacy for innovative, pioneering practices.

Pharmacists interact with patients more than any other member of the health care team, therefore it is vital they help address barriers and gaps in member care that impact plan performance.

Pharmacists can play a direct role in addressing social disparities of health in low-income communities by building trust and providing expertise to patients.

Further integration with care teams and using data to demonstrate the value of pharmacists will be essential to maintaining the momentum created by the COVID-19 pandemic.

When looking at the COVID-19 variants, it is increasingly necessary to assess them in terms of the mutations embedded in the variants themselves.

During a session at the NACDS 2021 Annual Meeting, Scott Gottlieb, MD, former commissioner of the FDA from 2017 to 2019, provided an overview of where the country is heading in its response to the COVID-19 pandemic.

The efforts of pharmacists to keep their doors open during the pandemic, build COVID-19 testing sites, and prepare for and administer COVID-19 vaccinations took extraordinary investment and determination.

Cedric Richmond, senior advisor to President Biden and director of the White House Office of Public Engagement, thanked the NACDS and other health care providers for their hard work during a session at the 2021 NACDS Annual Meeting.

According to Michael Sneed, executive vice president of global corporate affairs and chief communication officer for Johnson & Johnson, the health care system has chronically left people of color behind, and the inequities seen throughout the COVID-19 pandemic are only the latest examples.

Clinicians should consider the impact on subsequent therapies, overall survival, and median time to definitive deterioration with CDK 4/6 inhibitors.

Open to all health care professionals, the PQA meeting is a top forum for learning best practices and emerging trends in medication services, pharmacist-provided care, and quality improvement initiatives.

Among somatic mutations, approximately 89% of patients with metastatic castration-resistant prostate cancer have a potentially actionable mutation.

Hematology/Oncology Pharmacy Association plans to develop tools and resources to support those conducting research in the oncology pharmacy field, with the goal of promoting pharmacist-led research and improving the ability to analyze difficult scientific questions.

Patient interactions became vastly different during the pandemic, with questions surrounding how to coordinate contact and how to best provide pharmacy services virtually, including counseling, fielding drug information questions, medication reconciliation, and providing home medication sheets to families

Olaparib and niraparib both show promise in the maintenance treatment of ovarian cancer, though they may each be appropriate for different patient populations.

Pharmacokinetic differences in pediatric patients should be considered when administering direct oral anticoagulants, as should potential administration difficulties when pellets or oral solutions are not available.

Selection of any BTK inhibitors for mantle cell lymphoma should consider factors such as cardiovascular or bleeding risks, predisposition for gastrointestinal adverse effects, and potential medication nonadherence.

CLL is the most common leukemia in adult patients in the western world, with 21,040 estimated new cases in 2020.

For unresectable gastrointestinal stromal tumors, the introduction of imatinib revolutionized treatment.

Urothelial carcinoma is the sixth most common cancer diagnosis in the United States, with an estimated 81,400 new diagnoses in 2020 and 17,980 deaths.